As a new finding, in analogy to previous publications, the clinical relevance of HLA-G is once again shown in these RCC data sets, as it correlates statistically significantly with the aggressiveness of the different RCC subtypes. This evidence concerns the gene HLA-G and renal cell carcinoma.